Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1991 2
1992 1
1993 2
1996 1
1998 1
1999 1
2000 2
2001 1
2003 1
2004 1
2005 1
2006 1
2016 1
2017 1
2018 1
2019 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The Patient-Centered Future of Clinical Pharmacology.
Shahin MH, Abdel-Rahman S, Hartman D, Johnson JA, Mitchell DY, Reynolds KS, Wagner JA, Morrissey KM. Shahin MH, et al. Among authors: mitchell dy. Clin Pharmacol Ther. 2020 Jan;107(1):72-75. doi: 10.1002/cpt.1681. Epub 2019 Nov 21. Clin Pharmacol Ther. 2020. PMID: 31751490 No abstract available.
The effect of dosing regimen on the pharmacokinetics of risedronate.
Mitchell DY, Heise MA, Pallone KA, Clay ME, Nesbitt JD, Russell DA, Melson CW. Mitchell DY, et al. Br J Clin Pharmacol. 1999 Oct;48(4):536-42. doi: 10.1046/j.1365-2125.1999.00035.x. Br J Clin Pharmacol. 1999. PMID: 10583024 Free PMC article. Clinical Trial.
Correction to Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group.
Robinson RP, Reiter LA, Barth WE, Campeta AM, Cooper K, Cronin BJ, Destito R, Donahue KM, Falkner FC, Fiese EF, Johnson DL, Kuperman AV, Liston TE, Malloy D, Martin JJ, Mitchell DY, Rusek FW, Shamblin SL, Wright CF. Robinson RP, et al. Among authors: mitchell dy. J Med Chem. 2018 Apr 12;61(7):3237. doi: 10.1021/acs.jmedchem.8b00306. Epub 2018 Mar 28. J Med Chem. 2018. PMID: 29589934 No abstract available.
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies.
Lorusso PM, Adjei AA, Varterasian M, Gadgeel S, Reid J, Mitchell DY, Hanson L, DeLuca P, Bruzek L, Piens J, Asbury P, Van Becelaere K, Herrera R, Sebolt-Leopold J, Meyer MB. Lorusso PM, et al. Among authors: mitchell dy. J Clin Oncol. 2005 Aug 10;23(23):5281-93. doi: 10.1200/JCO.2005.14.415. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009947 Clinical Trial.
23 results